Siddhivinayak Critical Care Centre Profile
Key Indicators
- Authorised Capital ₹ 2.10 M
as on 29-12-2024
- Paid Up Capital ₹ 0.18 M
as on 29-12-2024
- Company Age 23 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.57 M
as on 29-12-2024
- Revenue 48.71%
(FY 2022)
- Profit 419.56%
(FY 2022)
- Ebitda 218.03%
(FY 2022)
- Net Worth 4.31%
(FY 2022)
- Total Assets 4.16%
(FY 2022)
About Siddhivinayak Critical Care Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹2.57 M.
Girish Gajare and Jyoti Gajare serve as directors at the Company.
- CIN/LLPIN
U85110MH2001PTC131094
- Company No.
131094
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2001
- Date of AGM
09 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Jalgaon, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Siddhivinayak Critical Care Centre?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Girish Gajare | Director | 05-Mar-2001 | Current |
Jyoti Gajare | Director | 05-Mar-2001 | Current |
Financial Performance of Siddhivinayak Critical Care Centre.
Siddhivinayak Critical Care Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.71% increase. The company also saw a substantial improvement in profitability, with a 419.56% increase in profit. The company's net worth moved up by a moderate rise of 4.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Siddhivinayak Critical Care Centre?
In 2020, Siddhivinayak Critical Care Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Siddhivinayak Agro & Trade Private LimitedActive 17 years 1 month
Girish Gajare and Jyoti Gajare are mutual person
- Ganpati Diagnostic And Research Centre Private LimitedActive 26 years 3 months
Girish Gajare is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Icici Bank Limited Creation Date: 27 Jul 2005 | ₹2.57 M | Open |
How Many Employees Work at Siddhivinayak Critical Care Centre?
Unlock and access historical data on people associated with Siddhivinayak Critical Care Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siddhivinayak Critical Care Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siddhivinayak Critical Care Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.